Journal Watch · Proceedings of the National Academy of Sciences (PNAS) · 2026

RelB NF-κB tunes Notch2 signaling to promote IL-23-secreting solitary isolated lymphoid tissue-resident DCs critical for gut immunity.

In sum, we illustrate a previously unrecognized crosstalk between RelB and Notch2 underpinning IL-23-secreting DCs critical for gut immunity.

Kumar N, Deka A, Basu S et al.Proceedings of the National Academy of Sciences (PNAS)3 min readPharma relevance 40/100

DOI: 10.1073/pnas.2600771123PMID: 42525520Study type: preclinical (animal / model) study

TL;DR

In sum, we illustrate a previously unrecognized crosstalk between RelB and Notch2 underpinning IL-23-secreting DCs critical for gut immunity.

Key findings

  • Indeed, we found that IL-23 supplementation readily rescued the immune deficiency of <i>Relb<sup>ΔCD11c</sup></i> mice, improving bacterial clearance.
  • In sum, we illustrate a previously unrecognized crosstalk between RelB and Notch2 underpinning IL-23-secreting DCs critical for gut immunity.

What they did

Here, we show that genetic ablation of RelB in DCs compromises IL-23-dependent immune response in the intestine, imparting vulnerability in <i>Relb<sup>ΔCD11c</sup></i> mice to infection with <i><i>Citrobacter</i> rodentium</i>, an enteropathogen. Our mechanistic studies revealed that RelB supported the expression of RBP-J from a κB site-driven promoter, tuning Notch2 response in DCs. This RelB-mediated Notch2 control specified a solitary isolated lymphoid tissue-resident DC subset, which served as a dominant source of IL-23 in infected mice.

Full abstract (original)

Background: While preserving tolerance toward commensals, dendritic cells (DCs) also orchestrate response against pathogens. The noncanonical RelB NF-κB pathway in DCs curbs tolerogenic Tregs in the intestine. Whether RelB-dependent DC regulations also impact intestinal immunity remains less clear.

What they did: Here, we show that genetic ablation of RelB in DCs compromises IL-23-dependent immune response in the intestine, imparting vulnerability in <i>Relb<sup>ΔCD11c</sup></i> mice to infection with <i><i>Citrobacter</i> rodentium</i>, an enteropathogen. Our mechanistic studies revealed that RelB supported the expression of RBP-J from a κB site-driven promoter, tuning Notch2 response in DCs. This RelB-mediated Notch2 control specified a solitary isolated lymphoid tissue-resident DC subset, which served as a dominant source of IL-23 in infected mice.

Results & conclusions: Indeed, we found that IL-23 supplementation readily rescued the immune deficiency of <i>Relb<sup>ΔCD11c</sup></i> mice, improving bacterial clearance. In sum, we illustrate a previously unrecognized crosstalk between RelB and Notch2 underpinning IL-23-secreting DCs critical for gut immunity.

Abstract © the authors / Proceedings of the National Academy of Sciences (PNAS) (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1073/pnas.2600771123 · PubMed 42525520.

Why it matters for pharma & biotech

  • Relevant to General & Medicine teams tracking Proceedings of the National Academy of Sciences (PNAS) for new targets, mechanisms and biomarkers.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • The work is preclinical. Results in animal or cell models frequently do not translate directly to human efficacy or safety.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this Proceedings of the National Academy of Sciences (PNAS) study find?

In sum, we illustrate a previously unrecognized crosstalk between RelB and Notch2 underpinning IL-23-secreting DCs critical for gut immunity.

What type of study is this?

It is a preclinical (animal / model) study, published in Proceedings of the National Academy of Sciences (PNAS) in 2026. Here, we show that genetic ablation of RelB in DCs compromises IL-23-dependent immune response in the intestine, imparting vulnerability in <i>Relb<sup>ΔCD11c</sup></i> mice to infection with <i><i>Citrobacter</i> rodentium</i>, an enteropathogen.

Where can I read the original paper?

The original is at the publisher via DOI 10.1073/pnas.2600771123. PubMed ID: 42525520. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Kumar N, Deka A, Basu S et al.. RelB NF-κB tunes Notch2 signaling to promote IL-23-secreting solitary isolated lymphoid tissue-resident DCs critical for gut immunity.. Proceedings of the National Academy of Sciences (PNAS) (2026). DOI: 10.1073/pnas.2600771123.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/relb-nf-b-tunes-notch2-signaling-to-promote-il-23-secreting-solitary-iso-771123/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides